Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsSelectHealth formulary coverage & Prior Auth | Ope…
    Ask Trek AI about this page
    CurrentSelectHealthPolicy N/A

    Prescription drug list (formulary) - Coverage Criteria

    Customize your policy alerts

    Sign up for all SelectHealth policy alerts

    Know when SelectHealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This document is a summary of commonly prescribed drugs covered by SelectHealth plans (the formulary), including tier placement, special requirements (e.g., preauthorization, step therapy, quantity limits, age limits), and guidance for members and providers on coverage and costs.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerSelectHealth
    PolicyPrescription drug list (formulary) - Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJan 1, 2026
    Next Review Date
    Key ActionObtain prior authorization when a drug is marked with (PA) before expecting coverage.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    monthlyformulary review frequency
    800-538-5038Pharmacy Services
    90-day90-day option
    PA, QL, M, ST, AGErequirement tags observed
    6document part

    Coverage Criteria Overview

    This formulary extract lists covered prescription drugs and also identifies medications that are not covered by the plan. For drugs that are not covered, a coverage exception may be requested by the member, the prescribing physician, or the dispensing pharmacy. Requests for coverage of noncovered drugs are considered on a case‑by‑case basis and must demonstrate medical necessity. To initiate a request, submit the Drug Coverage Exception Form available on the plan website.

    Provider Actions, Authorization, and Documentation

    Prior Authorization

    Preauthorization Required

    Coverage of drugs is based on medical necessity. For certain drugs, preauthorization (PA) is required before the plan will cover the medication. If you do not obtain required preauthorization, the member may be financially responsible for the drug's full retail price.

    • Preauthorization required for select products — PA flags are shown in the product lists (e.g., many specialty, oncology, pulmonary arterial hypertension, and higher‑tier agents).
    • Absence of a required PA may result in claim denial or member financial responsibility.
    Prior Authorization

    Prior Authorization for Listed and Higher‑Tier Drugs

    Some listed drugs and higher‑tier products (notably Tier 5–6 and many specialty/oncology agents) carry a Prior Authorization requirement. Examples from the formulary include multiple oncology agents, PAH agents (e.g., Ambrisentan, Alyq), and certain Tier 5–6 injectables and oral specialty products.

    • Look for (PA) next to drug entries in the product lists — these products require prior authorization before coverage is approved.
    • Many Tier 5–6 products and specialty injectables have PA + QL + M flags; review the specific drug row for all requirement flags.
    Step Therapy

    Step Therapy Requirement and Risk

    Step therapy (ST) requires trying an alternative therapy first; coverage may be denied if step requirements are not met. Step therapy most often applies to brand‑name and certain specialty products.

    • Products tagged (ST) in the formulary must meet step‑through criteria prior to coverage.
    • Failure to satisfy step therapy requirements can cause claim denial or additional processing delays.
    Denial Risk

    Requirement Flags and Denial Risk

    Quantity limits (QL), age limits (AGE), medical justification (M), step therapy (ST), and prior authorization (PA) flags indicate additional requirements. If the corresponding requirement is not met or documented, claims may be denied or require additional review.

    • (QL): Quantity limits — exceeding limits may require PA or documentation and can result in denial.
    • (AGE): Age limits — verify member age for product eligibility.
    • (M): Medical documentation may be required to support medical necessity.
    • (ST)/(PA): Step therapy or prior authorization flags present on product rows are potential denial triggers if not satisfied.
    Documentation Required

    Documentation Expectations for Flagged Products

    Documentation must support any flagged requirement (PA, QL, ST, M, AGE). Provide clinical rationale, prior treatment history, relevant labs or imaging, and member age when applicable to expedite reviews.

    • For PA requests include diagnosis, prior therapies and dates, reason for failure or intolerance, and expected duration of therapy.
    • For QL or ST exceptions, include dosing history and justification for exceedance or bypassing step therapy.
    • Use the Drug Coverage Exception Form (available on our website) to request coverage for noncovered drugs or to request exceptions.
    • Incomplete documentation may delay review or lead to denial.
    Note

    Coverage Exception Requests

    Coverage exception requests (Drug Coverage Exception) may be submitted when a drug is not covered or when a member needs an exception to PA/QL/ST requirements. These are reviewed on a case‑by‑case basis.

    • Submit the Drug Coverage Exception Form found on the payer website.
    • Include supporting clinical documentation and the specific reason for the exception (e.g., prior therapy failure, contraindication, age exception).
    • If an exception is granted it will be documented and applied to the member’s coverage; if denied, standard PA and cost‑sharing rules apply.

    Formulary Flags and Definitions

    PA/ST/QL/M/AGE — Formulary flag definitions
    PAPreauthorization required — certain drugs require prior authorization before coverage; absence may make member responsible for full retail price.
    STStep therapy — coverage only after trial and failure or intolerance of an alternative therapy; commonly applies to brand-name drugs.
    QLQuantity Limit — plan limits apply to specified drugs; preauthorization required if requested quantity exceeds limits.
    MMaintenance — maintenance drugs may allow a 90-day supply option for continuation of therapy.
    AGEAge limit — a minimum or maximum age requirement must be met for coverage of specified products.
    Prior Authorization (PA)

    Step Therapy Requirements and Affected Products

    Drug / ProductTierRequirement(s)
    Adapalene Gel3(ST)
    Clindamy/Ben Gel4(ST)
    Dapsone4(ST)
    Icosapent Capsule4(ST)(QL)(M)
    Pitavastatin Tablet3(ST)(QL)(M)
    Repatha Injectable4(PA)(QL)(M); Repatha Injectable entry also shows (ST)(QL)
    Travoprost Dro (ophthalmic)4(ST)(QL)(M)
    Imvexxy Main Sup / Strt Sup (topical)5(ST)(QL)(M)
    Various ophthalmic prostaglandins (e.g., Bimatoprost, Latanoprost, Lumigan)2-4Some entries include (ST) or (QL)(M) as shown per product
    Additional Product ExampleTierRequirement(s)
    Icosapent Capsule4(ST)(QL)(M)
    Omega-3-Acid Capsule3(QL)(M)
    Pitavastatin Tablet3(ST)(QL)(M)
    Travoprost Dro4(ST)(QL)(M)
    Imvexxy Main Sup / Imvexxy Strt Sup5(ST)(QL)(M) / (ST)(M)
    Supplemental ProductTierRequirement(s)
    Adapalene Gel3(ST)
    Diltiazem (Dilt-Xr Capsule / Diltiazem)2-3(ST)(QL)(M)
    Ivermectin4(ST)(QL)
    Repatha Injectable (listed also with ST on another line)4(PA)(QL)(M) and elsewhere (ST)(QL)
    Travoprost Dro4(ST)(QL)(M)
    Agent / ProductTierRequirement(s)
    Adapalene Gel3(ST)
    Clindamy/Ben Gel4(ST)
    Dapsone4(ST) (one line also shows (AGE) on alternate entry)
    Pitavastatin Tablet3(ST)(QL)(M)
    Icosapent Capsule4(ST)(QL)(M)
    Repatha Injectable4(PA)(QL)(M) and listed with (ST)(QL) on another entry
    Imvexxy Main Sup / Imvexxy Strt Sup5(ST)(QL)(M) / (ST)(M)
    Travoprost Dro4(ST)(QL)(M)
    Various oncology and specialty agents (examples shown in section) - see entriesvariousSome oncology entries in the section are flagged with (ST) where shown

    Quantity Limits and Affected Drugs

    Various listed drugs — QL applies where indicated
    ScopeVarious listed drugs include (QL) in their Requirements & Limits field indicating quantity limits apply.
    ExamplesEntries such as Pro Voice Tes and Auvi-Q Injectable show (QL) on their requirements lines.
    ImplicationClaims exceeding the stated quantity limits may require prior authorization or be denied.
    Quantity limit tag presence across products
    Presence(QL) tag appears across multiple product entries and tiers in the formulary extract.
    Products affectedBoth lower-tier and specialty tier products (tiers 1–6) include QL flags in the extract.

    Background and Formulary Structure

    The formulary groups medications by therapeutic category and assigns them to cost tiers. Entries may show special administrative requirements and limits using shorthand flags: PA = preauthorization required, ST = step therapy (trial of a preferred alternative required), QL = quantity limits, M = maintenance drug (90‑day supply option), and AGE = age‑based restrictions. The list is maintained and reviewed regularly by the clinical team; where flags appear on a drug line, applicable documentation or prior approval must be obtained to secure coverage.

    Policy Summary
    PayerSelectHealth
    PolicyPrescription drug list (formulary) - Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJan 1, 2026
    Next Review Date
    Key ActionObtain prior authorization when a drug is marked with (PA) before expecting coverage.
    SourceLink
    On This Page
    Coverage Criteria OverviewProvider Actions, Authorization, and DocumentationFormulary Flags and DefinitionsStep Therapy Requirements and Affected ProductsQuantity Limits and Affected DrugsBackground and Formulary Structure
    Definition(PA) indicates Prior Authorization is required before coverage will be provided.
    Provider actionSubmit prior authorization request with supporting documentation demonstrating medical necessity as required by the plan.
    Risk if not metWithout required PA the claim may be denied and the member may be responsible for full retail cost.
    Quantity Limit (QL)
    Definition(QL) indicates Quantity Limits apply to the listed drug; quantities above plan limits may require prior authorization or be denied.
    Provider actionFor requests exceeding the QL, submit documentation to justify the medical necessity or request a quantity-limit exception.
    ExamplesQuantity limits often applied to opioids and other high-risk or high-cost agents in the formulary.
    Medical Management / Maintenance (M)
    Definition(M) indicates Maintenance — drugs considered for longer-term therapy and eligible for a 90-day supply option.
    Provider actionPrescribe maintenance drugs with 90-day supply where appropriate to support continuation of therapy.
    NoteMaintenance designation may also trigger medical management review for certain agents.
    Age limit (AGE)
    Definition(AGE) indicates an age limit — a minimum or maximum age requirement must be met for coverage of the product.
    Provider actionConfirm patient age meets the listed AGE requirement when requesting coverage or submitting claims.
    DocumentationAge-based restrictions should be documented in the medical record to support approvals or exception requests.
    Step Therapy (ST)
    Definition(ST) indicates Step Therapy — the member must try and fail (or be intolerant to) specified preferred alternatives before the listed drug is covered.
    Provider actionDocument prior trials and outcomes of required alternative therapies when submitting an authorization for an ST-tagged drug.
    Coverage implicationIf step therapy requirements are not met, the claim may be denied unless an exception is granted.
    Prior Authorization — short label
    Short labelPA
    Long formPrior Authorization
    Usage noteAppears next to products that require an authorization prior to coverage.
    Quantity Limit — short label
    Short labelQL
    Long formQuantity Limit
    Usage noteUsed to denote products subject to plan quantity limits; may require exception if exceeded.
    Step Therapy — short label
    Short labelST
    Long formStep Therapy
    Usage noteIndicates required trial of alternatives before coverage of the listed agent.
    Medical Management — short label
    Short labelM
    Long formMedical Management / Maintenance
    Usage noteMarks drugs eligible for 90-day maintenance supply and/or medical management review.
    Age limit — short label
    Short labelAGE
    Long formAge limit
    Usage noteDenotes minimum or maximum age requirement for coverage of the product.
    ActionFor QL-tagged products, verify plan limits before dispensing and submit exception requests as needed.
    Relion True Tes (Ondansetron) — QL example
    ProductRelion True Tes (Ondansetron)
    RequirementMarked with (QL) indicating quantity limits apply to this ondansetron product.
    ImplicationDispensing above the plan limit may require prior authorization or documentation to support the quantity.
    Multiple entries — (QL)-flagged products grouped
    GroupingMultiple product entries are flagged with (QL) in the Requirements & Limits column within oncology, ophthalmic, and other categories.
    Frequency(QL) appears repeatedly across the extract, indicating it is commonly applied across therapeutic classes.
    PracticeCheck QL designations when prescribing or dispensing to prevent denials or need for retrospective documentation.